SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-017733
Filing Date
2022-08-24
Accepted
2022-08-24 16:17:01
Documents
12
Period of Report
2022-08-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K alna-20220823.htm   iXBRL 8-K 64185
  Complete submission text file 0000950170-22-017733.txt   186425

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alna-20220823_lab.xml EX-101.LAB 13904
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alna-20220823_pre.xml EX-101.PRE 10238
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alna-20220823.xsd EX-101.SCH 2481
6 EXTRACTED XBRL INSTANCE DOCUMENT alna-20220823_htm.xml XML 4888
Mailing Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776
Business Address 142 -F NORTH ROAD, SUITE 150 SUDBURY MA 01776 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 221191750
SIC: 2836 Biological Products, (No Diagnostic Substances)